Advertisement
Screener

BRIACELL THERAPEUTICS CORP. (BCTX) Deferred Tax Assets, Operating Loss Carryforwards, Domestic

BRIACELL THERAPEUTICS CORP. Deferred Tax Assets, Operating Loss Carryforwards, Domestic

BRIACELL THERAPEUTICS CORP. (BCTX) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $40.45 million as of 2025-07-31, per its 10-K filed 2025-10-16.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components

us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2025-10-16

  • 2025-07-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $40.45M.
Period endDeferred Tax Assets, Operating Loss Carryforwards, Domestic
2025-07-31$40.45M
10-K · filed 2025-10-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
PMGC Holdings Inc. (ELAB)United States$0.037B
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Celularity Inc (CELU)United States$0.038B-0.34
CervoMed Inc. (CRVO)United States$0.038B-1.39
Edesa Biotech, Inc. (EDSA)Canada$0.039B
ROCKWELL MEDICAL, INC. (RMTI)United States$0.035B
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98